Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinoblastoma | 3 | 2014 | 317 | 0.830 |
Why?
|
| Neoplasms, Second Primary | 2 | 2014 | 1060 | 0.510 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 3 | 2021 | 493 | 0.510 |
Why?
|
| Medulloblastoma | 4 | 2015 | 677 | 0.500 |
Why?
|
| Cerebellar Neoplasms | 3 | 2015 | 585 | 0.490 |
Why?
|
| Germinoma | 3 | 2021 | 132 | 0.490 |
Why?
|
| Retinal Neoplasms | 2 | 2014 | 146 | 0.490 |
Why?
|
| Linear Energy Transfer | 2 | 2015 | 152 | 0.460 |
Why?
|
| Paraganglioma | 1 | 2013 | 142 | 0.390 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2013 | 549 | 0.330 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2013 | 304 | 0.330 |
Why?
|
| Delayed Diagnosis | 1 | 2013 | 463 | 0.330 |
Why?
|
| Hemangioma | 1 | 2013 | 727 | 0.310 |
Why?
|
| SEER Program | 1 | 2013 | 1532 | 0.300 |
Why?
|
| Spinal Neoplasms | 1 | 2014 | 716 | 0.290 |
Why?
|
| Hippocampus | 1 | 2019 | 3737 | 0.280 |
Why?
|
| Glioma | 1 | 2019 | 3420 | 0.240 |
Why?
|
| Lymphoma | 1 | 2013 | 1899 | 0.230 |
Why?
|
| Head and Neck Neoplasms | 2 | 2015 | 2880 | 0.200 |
Why?
|
| Brain Neoplasms | 5 | 2021 | 8984 | 0.200 |
Why?
|
| Carcinoma | 1 | 2013 | 2334 | 0.200 |
Why?
|
| Free Tissue Flaps | 2 | 2015 | 327 | 0.180 |
Why?
|
| Patient Advocacy | 1 | 2019 | 358 | 0.140 |
Why?
|
| Laryngectomy | 2 | 2017 | 243 | 0.140 |
Why?
|
| Larynx, Artificial | 1 | 2017 | 69 | 0.140 |
Why?
|
| Otolaryngology | 3 | 2019 | 685 | 0.140 |
Why?
|
| Relative Biological Effectiveness | 2 | 2015 | 312 | 0.130 |
Why?
|
| Speech, Alaryngeal | 1 | 2015 | 32 | 0.130 |
Why?
|
| Auditory Brain Stem Implants | 1 | 2015 | 31 | 0.130 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2015 | 917 | 0.130 |
Why?
|
| Cranial Irradiation | 2 | 2015 | 391 | 0.130 |
Why?
|
| Pharyngectomy | 1 | 2015 | 44 | 0.130 |
Why?
|
| Cervicoplasty | 1 | 2015 | 8 | 0.130 |
Why?
|
| Supratentorial Neoplasms | 2 | 2013 | 159 | 0.120 |
Why?
|
| Conflict of Interest | 1 | 2019 | 549 | 0.120 |
Why?
|
| Pituitary Gland, Posterior | 1 | 2013 | 42 | 0.110 |
Why?
|
| Voice Quality | 1 | 2015 | 226 | 0.110 |
Why?
|
| Adolescent | 10 | 2021 | 87747 | 0.110 |
Why?
|
| Child, Preschool | 9 | 2021 | 42034 | 0.110 |
Why?
|
| Prosthesis Implantation | 1 | 2017 | 593 | 0.110 |
Why?
|
| Drug Industry | 1 | 2019 | 789 | 0.110 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 2014 | 586 | 0.100 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2013 | 136 | 0.100 |
Why?
|
| Pineal Gland | 1 | 2013 | 157 | 0.100 |
Why?
|
| Monte Carlo Method | 2 | 2015 | 1256 | 0.100 |
Why?
|
| Neurofibromatosis 2 | 1 | 2015 | 385 | 0.100 |
Why?
|
| Travel | 1 | 2017 | 786 | 0.100 |
Why?
|
| Deafness | 1 | 2015 | 456 | 0.090 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2014 | 323 | 0.090 |
Why?
|
| Child | 9 | 2021 | 79758 | 0.090 |
Why?
|
| Postoperative Hemorrhage | 1 | 2015 | 422 | 0.090 |
Why?
|
| Rhabdoid Tumor | 1 | 2013 | 210 | 0.090 |
Why?
|
| Speech Perception | 1 | 2015 | 505 | 0.090 |
Why?
|
| Ependymoma | 1 | 2013 | 320 | 0.090 |
Why?
|
| Brain Stem | 1 | 2015 | 857 | 0.090 |
Why?
|
| Teratoma | 1 | 2013 | 403 | 0.090 |
Why?
|
| Memory | 1 | 2019 | 2179 | 0.080 |
Why?
|
| Radiotherapy, Conformal | 1 | 2013 | 549 | 0.080 |
Why?
|
| Radiation Oncology | 1 | 2015 | 563 | 0.080 |
Why?
|
| Survivors | 1 | 2019 | 2367 | 0.080 |
Why?
|
| Radiosurgery | 1 | 2017 | 1343 | 0.080 |
Why?
|
| Radiation Injuries | 1 | 2015 | 1183 | 0.080 |
Why?
|
| Blood Transfusion | 1 | 2015 | 1328 | 0.080 |
Why?
|
| Operating Rooms | 1 | 2014 | 790 | 0.080 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2013 | 1790 | 0.070 |
Why?
|
| Treatment Failure | 1 | 2014 | 2646 | 0.070 |
Why?
|
| Young Adult | 7 | 2021 | 58673 | 0.070 |
Why?
|
| Spinal Cord | 1 | 2015 | 1817 | 0.070 |
Why?
|
| Follow-Up Studies | 5 | 2015 | 39254 | 0.070 |
Why?
|
| Infant | 5 | 2014 | 36030 | 0.070 |
Why?
|
| Male | 17 | 2021 | 359413 | 0.060 |
Why?
|
| Humans | 22 | 2021 | 760261 | 0.060 |
Why?
|
| Clinical Competence | 2 | 2017 | 4786 | 0.060 |
Why?
|
| Cohort Studies | 4 | 2015 | 41317 | 0.060 |
Why?
|
| Retrospective Studies | 8 | 2021 | 80301 | 0.060 |
Why?
|
| Female | 15 | 2017 | 391011 | 0.060 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 3159 | 0.060 |
Why?
|
| Treatment Outcome | 7 | 2015 | 64947 | 0.060 |
Why?
|
| Radiotherapy Dosage | 3 | 2015 | 2897 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 14482 | 0.050 |
Why?
|
| Developing Countries | 1 | 2015 | 2880 | 0.050 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 6830 | 0.050 |
Why?
|
| Pediatrics | 2 | 2014 | 3587 | 0.050 |
Why?
|
| Recurrence | 1 | 2014 | 8487 | 0.050 |
Why?
|
| Incidence | 3 | 2015 | 21378 | 0.050 |
Why?
|
| Risk | 1 | 2013 | 9629 | 0.050 |
Why?
|
| Survival Rate | 1 | 2013 | 12806 | 0.040 |
Why?
|
| Prognosis | 3 | 2015 | 29636 | 0.040 |
Why?
|
| Internship and Residency | 2 | 2017 | 5867 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 5396 | 0.040 |
Why?
|
| Time Factors | 3 | 2015 | 40133 | 0.040 |
Why?
|
| Cognition | 1 | 2015 | 6948 | 0.040 |
Why?
|
| Punctures | 1 | 2017 | 367 | 0.030 |
Why?
|
| Esophagoscopy | 1 | 2017 | 391 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2017 | 11341 | 0.030 |
Why?
|
| Testicular Neoplasms | 1 | 2021 | 800 | 0.030 |
Why?
|
| Middle Aged | 5 | 2017 | 220175 | 0.030 |
Why?
|
| Radiography | 2 | 2015 | 6965 | 0.030 |
Why?
|
| Education, Medical, Graduate | 2 | 2017 | 2359 | 0.030 |
Why?
|
| Laryngeal Neoplasms | 1 | 2017 | 514 | 0.030 |
Why?
|
| Hematocrit | 1 | 2015 | 630 | 0.030 |
Why?
|
| Jejunum | 1 | 2015 | 472 | 0.030 |
Why?
|
| Equipment and Supplies | 1 | 2015 | 275 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2015 | 743 | 0.030 |
Why?
|
| Forearm | 1 | 2015 | 429 | 0.030 |
Why?
|
| alpha-Fetoproteins | 1 | 2013 | 222 | 0.030 |
Why?
|
| United States | 3 | 2017 | 72363 | 0.030 |
Why?
|
| Infratentorial Neoplasms | 1 | 2013 | 98 | 0.030 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2015 | 498 | 0.020 |
Why?
|
| Trachea | 1 | 2017 | 1082 | 0.020 |
Why?
|
| Esophagus | 1 | 2017 | 1023 | 0.020 |
Why?
|
| Chorionic Gonadotropin | 1 | 2013 | 457 | 0.020 |
Why?
|
| Adult | 3 | 2017 | 219847 | 0.020 |
Why?
|
| Endocrine System Diseases | 1 | 2013 | 251 | 0.020 |
Why?
|
| Length of Stay | 2 | 2015 | 6472 | 0.020 |
Why?
|
| Medical Staff, Hospital | 1 | 2014 | 600 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2017 | 1249 | 0.020 |
Why?
|
| Intelligence | 1 | 2015 | 919 | 0.020 |
Why?
|
| Comprehension | 1 | 2015 | 613 | 0.020 |
Why?
|
| Aged | 4 | 2017 | 168995 | 0.020 |
Why?
|
| Prostate | 1 | 2017 | 1793 | 0.020 |
Why?
|
| Cervical Vertebrae | 1 | 2015 | 978 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2013 | 36247 | 0.020 |
Why?
|
| Radiotherapy | 1 | 2015 | 1505 | 0.020 |
Why?
|
| Memory, Short-Term | 1 | 2015 | 977 | 0.020 |
Why?
|
| Cerebellum | 1 | 2015 | 1495 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 58947 | 0.020 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2013 | 781 | 0.020 |
Why?
|
| Body Height | 1 | 2013 | 1570 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2015 | 6242 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2013 | 1334 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 21065 | 0.020 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2014 | 1660 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2015 | 3764 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2014 | 2635 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2013 | 3531 | 0.010 |
Why?
|
| Linear Models | 1 | 2014 | 5876 | 0.010 |
Why?
|
| Graft Survival | 1 | 2015 | 3793 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2017 | 8553 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 2753 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 7803 | 0.010 |
Why?
|
| Cause of Death | 1 | 2013 | 3723 | 0.010 |
Why?
|
| Massachusetts | 1 | 2015 | 8805 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 5507 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 8551 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 12156 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 7016 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 25928 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2021 | 54263 | 0.010 |
Why?
|
| Quality of Life | 1 | 2015 | 13300 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2013 | 26168 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 13629 | 0.010 |
Why?
|
Concepts
(152)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(45)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_